Protide Pharmaceuticals
Protide Pharmaceuticals is a privately held, cGMP U.S. manufacturer of characterized, serum-free cell culture media, cryopreservation solutions, and cell processing reagents serving cell therapy, regenerative medicine, biopharma manufacturing, and vaccine production customers worldwide via distributors and direct quote-based sales.
- Company typePrivate
- Founded1985
- HeadquartersLake Zurich, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Protide Pharmaceuticals does
Protide Pharmaceuticals, Inc. is a privately held, U.S.-based specialty life sciences company that manufactures and sells characterized cell growth solutions, cryopreservation reagents, cell processing solutions, and a portfolio of CIT islet cell transplantation solutions. Founded in 1985 (formerly Celox Laboratories, Inc.) and headquartered at 345 Memorial Drive, Suite A, Crystal Lake, Illinois, Protide operates as a 1-10 employee organization running cGMP manufacturing at a single U.S. facility. Its core technology is built around defined, serum-free and serum-replacement formulations — including TCH (human-protein based), TCM/TM-235 (bovine-based), VaxMax (high-concentration for vaccine production), and HemaPro (human clonogenic supplement) — paired with cryopreservation chemistries such as Stemsol (USP DMSO), pZerve and Cellvation (DMSO-free), MiCord (DMSO/Dextran), and the 2-8CELLsius family with Type II Drug Master Files in process. The full workflow coverage spans serum-free media → cell processing (2-8CELLsius, Dextran 40, PBS, HBSS) → cryopreservation → clinical islet cell solutions, which gives the company a horizontal, workflow-level stake in cell therapy, regenerative medicine, and vaccine manufacturing rather than a single-asset product line. Protide also offers contract sterile-solution manufacturing services that leverage 36+ years of sterile fill experience for bespoke client formulations and packaging.
The business model is B2B consumables sales distributed through both direct quote-based e-commerce on the company website and a network of channel partners — globally via VWR International (Avantor), Sigma Aldrich, and MP Biomedicals, and regionally via Funakoshi (Japan), Nano Life Quest (Malaysia), and BioGroup Vietnam. Pricing is quote-driven and not publicly disclosed. Customer segmentation is horizontal across life science research institutions, biopharmaceutical manufacturers (recombinant proteins, vaccines, biologics), clinical cell therapy providers, and veterinary vaccine manufacturers; ISO 13485:2016 certification (achieved August 2023 via Eagle Registrations) and the in-process Drug Master Files position the company to compete for regulated clinical and cGMP accounts as well as research-volume demand. No acquisitions, no leadership turnover, and no external funding rounds have been disclosed, and ownership is described as founder/closely held; revenue, headcount growth, and capital structure figures are not publicly available.
Protide Pharmaceuticals firmographics
Firmographics- Name
- Protide Pharmaceuticals
- Legal name
- Protide Pharmaceuticals, Inc.
- Website
- https://protidepharma.com
- Company type
- Private
- Founded year
- 1985
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Protide Pharmaceuticals is a privately held, cGMP U.S. manufacturer of characterized, serum-free cell culture media, cryopreservation solutions, and cell processing reagents serving cell therapy, regenerative medicine, biopharma manufacturing, and vaccine production customers worldwide via distributors and direct quote-based sales.
- Ownership category
- akta.pro rank
Protide Pharmaceuticals industry classification
Industry- Product category
- Cell Culture and Cryopreservation Reagents
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Cell Therapy Manufacturing Services (GMP, autologous/allogeneic) (HLAAAKAC)
Keywords
Where Protide Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Lake Zurich
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Protide Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Product Sales - Serum Replacements and Biologics Production Media: Sale of cGMP-manufactured serum replacements including TCH, TCM, TM-235, HemaPro, and VaxMax for cell culture and biologics production. Products are sold as 50X concentrates in various sizes.
- Product Sales - Cryopreservatives: Sale of cryopreservation solutions including Stemsol (DMSO), pZerve, Cellvation, MiCord, and 2-8CELLsius + DMSO for various cell types including stem cells, islet cells, and progenitor cells.
- Product Sales - Cell Processing Solutions: Sale of cell processing solutions including 2-8CELLsius, Dextran 40, Dulbecco's PBS, and Hank's Balanced Salt Solution for cell washing and short-term storage.
- Product Sales - CIT Islet Cell Solutions: Complete islet cell transplantation solution portfolio including cold storage, purification, gradient, trimming, and phase I solutions.
- Contract Manufacturing Services: Custom manufacturing services leveraging 36+ years of sterile solution manufacturing experience including custom formulations, component modifications, and custom packaging.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Quote-based pricing for all products |
Go-to-market motion2 records
Distribution channels7 records
Marketing channels4 records
Protide Pharmaceuticals product offering
Product offeringCore offering
Protide Pharmaceuticals manufactures and sells characterized cell growth solutions (serum replacements), cryopreservation solutions (including DMSO-free options), cell processing reagents, and islet cell solutions for clinical transplantation. Their products are used by life science researchers, biopharmaceutical manufacturers, veterinary vaccine producers, and clinical cell therapy developers. They also offer custom contract manufacturing services for biopharmaceutical clients.
Product overview
Protide Pharmaceuticals is a fully integrated life sciences company offering a comprehensive portfolio of characterized cell growth solutions and cryopreservation technologies for regenerative medicine, cell therapy, and vaccine production. The product portfolio spans four main categories: (1) Serum-Replacements/Biologics Production Media including TCH (human protein-based), VaxMax (high-concentration for vaccines), HemaPro (human clonogenic supplement), TM-235, and TCM (bovine-based); (2) Cryopreservatives including Stemsol DMSO, pZerve (DMSO-free, animal protein-free), Cellvation (DMSO-free), MiCord, and 2-8CELLsius + DMSO; (3) Cell Processing products including 2-8CELLsius (washing/short-term storage), Dextran 40, Dulbecco's PBS (1X and 10X), and Hank's Balanced Salt Solution; (4) CIT Islet Cell Solutions including cold storage, purification, phase, gradient, trimming solutions, and RPMI 1640 medium. All products are cGMP manufactured in the USA, with 40+ years of experience serving clinical cell therapy, regenerative medicine, and cell engineering applications.
Differentiator
Problem solved
Functional benefit
Products and services
- TCH Serum Replacement Characterized serum replacement used as a cell growth solution for cell therapy and regenerative medicine research and manufacturing applications.
- VaxMax Serum Replacement Characterized serum replacement designed for veterinary vaccine production applications.
- HemaPro Serum Replacement Characterized serum replacement formulated for hematopoietic cell growth applications.
- TM-235 Serum Replacement Characterized serum replacement used as a cell growth solution for cell therapy, regenerative medicine, and vaccine production applications.
- TCM Serum Replacement Characterized serum replacement used as a cell growth solution for cell therapy and regenerative medicine applications.
- Stemsol USP (DMSO) Cryopreservation solution containing USP-grade DMSO for cryopreserving cells used in cell therapy and regenerative medicine applications.
- pZerve DMSO-free cryopreservation solution for cells used in cell therapy and regenerative medicine applications.
- Cellvation Cryopreservation solution for cells used in cell therapy and regenerative medicine applications.
- MiCord Cryopreservation solution designed for umbilical cord blood and cell therapy applications.
- 2-8CELLsius + DMSO Cryopreservation solution that combines 2-8CELLsius with DMSO for cell therapy and regenerative medicine applications.
- 2-8CELLsius DMSO-free cell processing solution used for cell washing, processing, and storage in cell therapy and regenerative medicine applications; also offered in alternative packaging formats.
- Dextran 40 Cell processing reagent used in cell isolation and processing workflows for research and clinical cell therapy applications.
- Dulbecco's PBS (1X and 10X) Phosphate-buffered saline solutions offered in 1X and 10X concentrations for cell washing and processing applications.
- Hank's Balanced Salt Solution (HBSS) Balanced salt solution used for cell washing and processing in research and clinical cell therapy applications.
- CIT Islet Cell Solutions A suite of products (Cold Storage/Purification Stock Solution, Phase I Solution, Gradient Stock Solution, 10% Penta Starch, Trimming Solution, and RPMI 1640) used in the isolation, purification, and storage of islet cells for clinical transplantation.
- Contract Manufacturing Services Custom contract manufacturing services for biopharmaceutical clients, providing development and production of cell-based products under cGMP conditions.
Quantifiable outcome
- Hundreds of clinical trials have used Protide technology
Companies that use Protide Pharmaceuticals
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles4 records
Protide Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Protide Pharmaceuticals partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- VWR International LLCcoreProtide completed a distribution agreement with VWR International LLC, an Avantor, Inc. company. Protide supports VWR's life science catalog with Characterized Cell Growth, Cell Processing, and Cryopreservation solutions. This partnership extends global reach through VWR's established distribution network.
- Sigma AldrichcoreGlobal distribution partnership for Protide products through Sigma Aldrich's extensive life science distribution network.
- MP BiomedicalscoreGlobal distribution partnership for Protide products through MP Biomedicals' distribution network.
- Funakoshi Co., LtdminorRegional distribution partnership for Protide products in Japan through Funakoshi, serving the Japanese life science research market.
- Nano Life Quest Sdn BhdminorRegional distribution partnership for Protide products in Malaysia and surrounding regions through Nano Life Quest.
- BioGroup Vietnam Co. LtdminorRegional distribution partnership for Protide products in Vietnam through BioGroup Vietnam.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Protide Pharmaceuticals competitors and assessment
Company assessmentBroad incumbents
- Bio-Techne:
- Cytiva (Danaher): Cytiva supplies cell culture media, buffers, and bioprocessing solutions for cell therapy and regenerative medicine applications, including cryopreservation formats. It overlaps with Protide's PBS, HBSS, and cryopreservation offerings as part of a much wider bioprocessing catalog.
- Lonza Group: Lonza is the largest cell and gene therapy contract manufacturer and a major supplier of cell culture media and cryopreservation solutions. It competes with Protide in serum-free media, cryopreservation reagents, and GMP cell therapy manufacturing services, but serves the same customer base with a much broader portfolio.
- Thermo Fisher Scientific: Through Gibco and Patheon, Thermo Fisher offers serum-free media, cryopreservation media, and cell processing buffers used in cell therapy and regenerative medicine workflows, directly overlapping with Protide's serum replacements and cryopreservation solutions.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Protide Pharmaceuticals social profiles
Digital presenceProtide Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Protide Pharmaceuticals leadership team
Management profileNumber of profiles
Protide Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Protide Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Protide Pharmaceuticals
What does Protide Pharmaceuticals do?
Protide Pharmaceuticals manufactures and sells characterized cell growth solutions (serum replacements), cryopreservation solutions (including DMSO-free options), cell processing reagents, and islet cell solutions for clinical transplantation. Their products are used by life science researchers, biopharmaceutical manufacturers, veterinary vaccine producers, and clinical cell therapy developers. They also offer custom contract manufacturing services for biopharmaceutical clients.
Is Protide Pharmaceuticals a public or private company?
Protide Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Protide Pharmaceuticals founded?
Protide Pharmaceuticals was founded in 1985. It employs 1 to 10 people.
Where is Protide Pharmaceuticals based?
Protide Pharmaceuticals is headquartered in Lake Zurich, United States, in the North America region.
How does Protide Pharmaceuticals make money?
Five revenue lines are on record. Product Sales - Serum Replacements and Biologics Production Media is the primary driver. The others are product Sales - Cryopreservatives, product Sales - Cell Processing Solutions, product Sales - CIT Islet Cell Solutions and contract Manufacturing Services.
Who are Protide Pharmaceuticals's main competitors?
Broad incumbents on record are Bio-Techne, Cytiva (Danaher), Lonza Group and Thermo Fisher Scientific.
Does Protide Pharmaceuticals have an API?
No public API is recorded for Protide Pharmaceuticals.
What industry is Protide Pharmaceuticals in?
Protide Pharmaceuticals's product category is Cell Culture and Cryopreservation Reagents. Its primary akta.pro industry code is HLAAAKAC, Cell Therapy Manufacturing Services (GMP, autologous/allogeneic). Its NAICS code is 325414 and its SIC code is 2836.